BlackRock’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-38,689
Closed -$7.35K 5525
2023
Q2
$7.35K Sell
38,689
-96,923
-71% -$18.4K ﹤0.01% 5192
2023
Q1
$46.1K Buy
135,612
+3,918
+3% +$1.33K ﹤0.01% 5049
2022
Q4
$42.6K Buy
131,694
+2,612
+2% +$844 ﹤0.01% 5180
2022
Q3
$53K Sell
129,082
-3,265
-2% -$1.34K ﹤0.01% 5253
2022
Q2
$58K Sell
132,347
-3,138
-2% -$1.38K ﹤0.01% 5291
2022
Q1
$171K Sell
135,485
-175
-0.1% -$221 ﹤0.01% 5056
2021
Q4
$176K Sell
135,660
-2,008
-1% -$2.61K ﹤0.01% 5060
2021
Q3
$283K Sell
137,668
-21,997
-14% -$45.2K ﹤0.01% 4834
2021
Q2
$252K Sell
159,665
-1,768,785
-92% -$2.79M ﹤0.01% 4778
2021
Q1
$4.28M Buy
1,928,450
+63,399
+3% +$141K ﹤0.01% 3947
2020
Q4
$4.63M Sell
1,865,051
-3,557
-0.2% -$8.82K ﹤0.01% 3676
2020
Q3
$4.6M Buy
1,868,608
+4,269
+0.2% +$10.5K ﹤0.01% 3518
2020
Q2
$6.62M Buy
1,864,339
+1,746,923
+1,488% +$6.2M ﹤0.01% 3346
2020
Q1
$275K Sell
117,416
-8,134
-6% -$19.1K ﹤0.01% 4096
2019
Q4
$276K Sell
125,550
-5,221
-4% -$11.5K ﹤0.01% 4214
2019
Q3
$239K Sell
130,771
-1,798
-1% -$3.29K ﹤0.01% 4251
2019
Q2
$191K Sell
132,569
-1,509,094
-92% -$2.17M ﹤0.01% 4315
2019
Q1
$3.23M Buy
1,641,663
+7,336
+0.4% +$14.5K ﹤0.01% 3519
2018
Q4
$2.14M Sell
1,634,327
-215
-0% -$282 ﹤0.01% 3609
2018
Q3
$4.02M Buy
1,634,542
+16,083
+1% +$39.6K ﹤0.01% 3517
2018
Q2
$5.44M Buy
1,618,459
+299,752
+23% +$1.01M ﹤0.01% 3444
2018
Q1
$5.58M Buy
1,318,707
+35,035
+3% +$148K ﹤0.01% 3347
2017
Q4
$4.24M Buy
1,283,672
+23,444
+2% +$77.4K ﹤0.01% 3451
2017
Q3
$4.81M Buy
1,260,228
+9,085
+0.7% +$34.7K ﹤0.01% 3419
2017
Q2
$5.51M Buy
1,251,143
+1,167,968
+1,404% +$5.14M ﹤0.01% 3407
2017
Q1
$302K Buy
+83,175
New +$302K ﹤0.01% 4061